| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701122 | European Journal of Surgical Oncology (EJSO) | 2016 | 9 Pages |
Abstract
Although conceptual, these data suggest that neoadjuvant therapy offers substantial benefit in LE and QALE for resectable pancreatic cancer patients. These findings highlight the value of further prospective randomized trials comparing neoadjuvant therapy to conventional upfront surgical strategies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S.W.L. de Geus, D.B. Evans, L.A. Bliss, M.F. Eskander, J.K. Smith, R.A. Wolff, R.A. Miksad, M.C. Weinstein, J.F. Tseng,